PASELLO, GIULIA

PASELLO, GIULIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 172 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-2016 2025 Pasello, Giulia + LUNG CANCER - -
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257) 2025 Pasello, GiuliaPigato, GiuliaScattolin, DanielaLando, StefaniaPotente, SaraRomualdi, ChiaraMaso, Alessandro DalBonanno, LauraGuarneri, ValentinaIndraccolo, Stefano + JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH - -
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study 2025 Pasello, Giulia + JOURNAL FOR IMMUNOTHERAPY OF CANCER - -
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer 2025 Dal Maso, AlessandroMinuzzo, Sonia AnnaPezzuto, FedericaZulato, ElisabettaPasello, GiuliaCalabrese, FiorellaFassan, MatteoRea, FedericoGuarneri, ValentinaIndraccolo, StefanoBonanno, Laura + FRONTIERS IN ONCOLOGY - -
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial 2025 Pasello, Giulia + LUNG CANCER - -
NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts' Study 2025 Buja, AlessandraRea, FedericoZanovello, AnnaPasello, GiuliaGuarneri, Valentina + CANCERS - -
Patterns of Comorbidities in Lung Cancer Patients and Survival 2025 Buja, AlessandraRea, FedericoRigon, LeonardoArcara, GiorgioPasello, GiuliaGuarneri, Valentina + CANCERS - -
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer 2025 Pasello, Giulia + THE ONCOLOGIST - -
Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer 2025 Pasello, Giulia + LUNG CANCER - -
Surgery for Pancoast Tumors in Multimodality Setting: Analysis of Outcomes and Risk Factors 2025 Cannone, GiorgioFaccioli, EleonoraMaggioni, GiuseppeSchiavon, MarcoComacchio, GiovanniMammana, MarcoPasello, GiuliaCalabrese, FiorellaDell'Amore, AndreaRea, Federico + JOURNAL OF CLINICAL MEDICINE - -
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME) 2025 Pasello, Giulia + CANCERS - -
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report 2024 Spagnolo, PaoloPasello, Giulia + JOURNAL OF PERSONALIZED MEDICINE - -
Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC 2024 Zulato, ElisabettaPasello, GiuliaGuarneri, ValentinaIndraccolo, StefanoBonanno, Laura + SCIENTIFIC REPORTS - -
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 2024 Bottosso, MicheleDieci, Maria VittoriaMiglietta, FedericaBonanno, LauraGuarneri, ValentinaGriguolo, GaiaPasello, Giulia + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations 2024 Salizzato, ValentinaPiccin, LuisaContato, AnnaPasello, Giulia + THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS - -
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671) 2024 Giuliano, MBrambilla, MRulli, EPasello, G + ANNALS OF ONCOLOGY - -
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment 2024 Tosi, AnnaPavan, AlbertoBonanno, LauraCalabrese, FiorellaGuarneri, ValentinaRosato, AntonioPasello, Giulia + JOURNAL FOR IMMUNOTHERAPY OF CANCER - -
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis 2024 Pasello, GiuliaPavan, AlbertoDal Maso, AlessandroBonanno, LauraGuarneri, Valentina + FRONTIERS IN ONCOLOGY - -
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 2024 Bonanno, LauraZingone, FabianaBarberio, BrigidaDal Maso, AlessandroPasello, GiuliaDei Tos, Angelo PaoloFassan, MatteoSavarino, Edoardo VincenzoGuarneri, Valentina + THE ONCOLOGIST - -
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database 2024 Pelizzari, GPasello, G + ESMO OPEN - -